Search Case Studies
Research demonstrated that a slower rate of infant weight gain had long-term health benefits. This work changed public health policies and initiatives in the UK and elsewhere, and infant formulas have been redesigned as a result.
Research at the UCL Institute of Child Health underpinned the update in 2009 of children’s growth charts, which are now in universal use throughout the UK. Modified versions of the charts are also used in Ireland and New Zealand.
UCL research into the genetics of deafness has resulted in the introduction of new diagnostic tests, which are now included in healthcare guidelines and professional standards.
A test for autistic spectrum disorders now included in healthcare guidelines and professional standards around the world, has significantly improved diagnosis of these conditions.
The management of childhood pleural empyema has been standardised and improved as a direct result of research at the UCL Institute of Child Health.
Research has led to the successful treatment of children with primary immunodeficiency diseases for whom there was little chance of 'cure' by the only other possible means: haematopoietic stem cell transplantation.
Evaluating and introducing pneumococcal conjugate vaccines into the UK infant immunisation programme
Efforts by the UCL Institute of Child Health Vaccine Evaluation Laboratory to evaluate pneumococcal conjugate vaccines have led to the vaccines' introduction into the infant immunisation schedule in the UK.
Since 1993, research at UCL has investigated alternative approaches to medication for children affected by epilepsy, with a particular emphasis on the roles of surgery and dietary treatments as alternatives to anti-epileptic drugs.
UCL research developed a new method of treating convulsive status epilepticus (a severe form of epileptic seizure). This has become the standard method of treatment.